542665 Stock Overview
Engages in the manufacture and sale of specialty chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Neogen Chemicals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,176.05 |
| 52 Week High | ₹2,414.90 |
| 52 Week Low | ₹1,148.80 |
| Beta | 0.44 |
| 1 Month Change | -7.36% |
| 3 Month Change | 0.56% |
| 1 Year Change | 45.63% |
| 3 Year Change | 21.39% |
| 5 Year Change | 469.95% |
| Change since IPO | 725.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542665 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.1% | -0.8% | -1.1% |
| 1Y | 45.6% | 3.4% | 15.0% |
Return vs Industry: 542665 exceeded the Indian Chemicals industry which returned 3.4% over the past year.
Return vs Market: 542665 exceeded the Indian Market which returned 15% over the past year.
Price Volatility
| 542665 volatility | |
|---|---|
| 542665 Average Weekly Movement | 7.1% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 542665 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 542665's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 588 | Haridas Kanani | www.neogenchem.com |
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates; as well as chemistries, such as alkylation, acylation, aminatin, oxidation, dehalogenation, silylation, halex reaction, friedel craft, couplings, and chlorination; custom synthesis; and contract manufacturing services.
Neogen Chemicals Limited Fundamentals Summary
| 542665 fundamental statistics | |
|---|---|
| Market cap | ₹56.29b |
| Earnings (TTM) | ₹403.90m |
| Revenue (TTM) | ₹7.37b |
142.5x
P/E Ratio7.8x
P/S RatioIs 542665 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542665 income statement (TTM) | |
|---|---|
| Revenue | ₹7.37b |
| Cost of Revenue | ₹4.14b |
| Gross Profit | ₹3.23b |
| Other Expenses | ₹2.83b |
| Earnings | ₹403.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.31 |
| Gross Margin | 43.80% |
| Net Profit Margin | 5.48% |
| Debt/Equity Ratio | 64.8% |
How did 542665 perform over the long term?
See historical performance and comparisonDividends
0.09%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/09 14:51 |
| End of Day Share Price | 2025/01/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Neogen Chemicals Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nav Bhardwaj | Anand Rathi Shares and Stock Brokers Limited |
| Bhawana Israni | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |